πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 750 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8143378

Polymer factor VIII moiety conjugates

Nektar Therapeutics Β· Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8138312

Compositions for regulation of tumor necrosis factor-alpha

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8137960

Bovine adeno-associated viral (BAAV) vector and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8138140

Self-assembling peptide amphiphiles and related methods for growth factor delivery

Northwestern University Β· Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8133915

Interleukin-1 and tumor necrosis factor-Ξ± modulators; syntheses of such modulators and met

The Regents of the University of California Β· Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8133859

SCGB3A2 as a growth factor and anti-apoptotic agent

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8133865

von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage

Nektar Therapeutics Β· Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8133977

Polymer-factor VIII moiety conjugates

Nektar Therapeutics Β· Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8123541

Electrical connector with expanded cover

Hon Hai Precision Ind. Co., Ltd. Β· Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8101739

Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) ang

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8080246

Colony stimulating factor 1 receptor (CSF1R) extracellular domain fusion molecules

Five Prime Therapeutics, Inc. Β· Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8071323

Human monoclonal antibodies that bind human insulin like growth factors and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8058403

Antibodies to stromal cell-derived factor-1 polypeptides

Five Prime Therapeutics, Inc. Β· Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8058226

Albumin-free factor VIII formulations

UNIVERSITY OF CONNECTICUT Β· Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8003692

Methods and compositions to inhibit edema factor and adenylyl cyclase

The Board of Regents of the University of Texas System Β· Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7999082

Anti-factor B antibodies

The Regents of the University of Colorado Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7988967

High affinity human antibodies to human nerve growth factor

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964576

Anti-arthropod vector vaccines, methods of selecting and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7951356

Tissue factor compositions and kits for coagulation and tumor treatment

The Board of Regents of the University of Texas System Β· Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7922999

Administration of growth factors for the treatment of CNS disorders

The Regents of the University of California Β· Granted Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919301

Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of reco

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919583

Integration-site directed vector systems

Discovery Genomics, Inc. Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7892008

Electrical connector having metallic lock

Hon Hai Precision Ind. Co., Ltd. Β· Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7893299

Interleukin-1 and tumor necrosis factor-Ξ±modulators; syntheses of such modulators and meth

The Regents of the University of California Β· Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted